Refractory Angina—An Overview and Recent Trends
| Autor: | Meenakshi Kadiyala, Chandrshekaran Krishnaswamy, Rameshwar Roopchandar |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
myocardial oxygen demand
education.field_of_study medicine.medical_specialty refractory angina business.industry Immunology Population lcsh:Surgery lcsh:RD1-811 Chest pain medicine.disease Review article law.invention Coronary artery disease Angina Randomized controlled trial Quality of life law medicine Life expectancy medicine.symptom education business Intensive care medicine coronary artery disease |
| Zdroj: | Indian Journal of Cardiovascular Disease in Women, Vol 02, Iss 04, Pp 094-098 (2017) |
| ISSN: | 2455-7854 |
| DOI: | 10.1055/s-0038-1622966 |
| Popis: | Because of improvement in survival from coronary artery disease and increasing life expectancy of the population, chronicity and resistance to therapy have become growing problems confronting the cardiologist. Refractory angina pectoris is an entity based on clinical diagnosis, and it refers to recurrent and sustained chest pain more than 3 months duration caused by coronary insufficiency that is unamenable to conventional modalities of treatment, including drugs, percutaneous coronary interventions, or coronary bypass grafting. Individuals with this entity may have an impaired quality of life, with recurrent angina, poor general health and psychological distress impairing functional and productive sustenance. A multitude of therapeutic options exists for patients with refractory angina pectoris, and randomized trials have shown them to be reasonably effective in reducing symptoms, though further research is warranted. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|